Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Renata Pukło"'
Autor:
Ewa Bromek, Anna Haduch, Marta Rysz, Joanna Jastrzębska, Renata Pukło, Olga Wójcikowska, Przemysław Jan Danek, Władysława Anna Daniel
Publikováno v:
Pharmaceutics, Vol 13, Iss 10, p 1643 (2021)
Recent research indicates that selective NMDA receptor GluN2B subunit antagonists may become useful for the treatment of major depressive disorders. We aimed to examine in parallel the effect of the selective NMDA receptor GluN2B subunit antagonist C
Externí odkaz:
https://doaj.org/article/8d90baaf32da49e78413385ceca134eb
Autor:
Anna Haduch, Ewa Bromek, Renata Pukło, Joanna Jastrzębska, Przemysław Jan Danek, Władysława Anna Daniel
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 22; Pages: 13746
The CYP2D enzymes of the cytochrome P450 superfamily play an important role in psychopharmacology, since they are engaged in the metabolism of psychotropic drugs and endogenous neuroactive substrates, which mediate brain neurotransmission and the the
Autor:
Władysława A. Daniel, Paulina Surówka, Patrycja Kleczkowska, Magdalena Zadrożny-Bujalska, Joanna Jastrzębska, Renata Pieniążek, Agata Suder, Renata Pukło, Małgorzata Filip, Małgorzata Frankowska
Publikováno v:
Pharmacological Reports
Background Opioid use disorders are serious contributors to the harms associated with the drug use. Unfortunately, therapeutic interventions for opioid addicts after detoxification have been limited and not sufficiently effective. Recently, several s
Autor:
Ewa Bromek, Przemysław Jan Danek, Jacek Wójcikowski, Agnieszka Basińska-Ziobroń, Renata Pukło, Joanna Solich, Marta Dziedzicka-Wasylewska, Władysława Anna Daniel
Publikováno v:
Pharmacological reports : PR. 74(5)
Background Our earlier studies have shown that the brain noradrenergic system regulates cytochrome P450 (CYP) in rat liver via neuroendocrine mechanism. In the present work, a comparative study on the effect of intraperitoneal administration of the n
Autor:
Renata Pukło, Magdalena Łasoń, Władysława A. Daniel, Mariusz Papp, Ewa Bromek, Anna Haduch, Marta Rysz, Monika Niemczyk, Piotr Gruca
Publikováno v:
Pharmacological Reports
Background The aim of our research was to determine the effects of chronic treatment with the atypical antidepressant agomelatine on the expression and activity of liver cytochrome P450 (CYP) in the chronic mild stress (CMS) model of depression, and
Autor:
Michael Bader, Agnieszka Nikiforuk, Anna Haduch, Renata Pukło, Piotr Popik, Natalia Alenina, Władysława A. Daniel
Publikováno v:
Neurochemistry international. 141
Brain cytochrome P450 (CYP) contributes to the local metabolism of endogenous substrates and drugs. The aim of present study was to ascertain whether the cytochrome P450 2D (CYP2D) activity changes with ageing and in cerebral serotonin deficit. Kinet
Autor:
Natalia Alenina, Władysława A. Daniel, Renata Pukło, Michael Bader, Wojciech Kuban, Anna Haduch, Joanna Golebiowska, Piotr Popik, Przemysław J Danek
Publikováno v:
Neurochemistry International. 152:105223
Among the enzymes that support brain metabolism, cytochrome P450 (CYP) enzymes occupy an important place. These enzymes catalyze the biotransformation pathways of neuroactive endogenous substrates (neurosteroids, neurotransmitters) and are necessary
Autor:
Anna Haduch, Władysława A. Daniel, Marta Rysz, Olga Wójcikowska, Przemysław J Danek, Ewa Bromek, Renata Pukło, Joanna Jastrzębska
Publikováno v:
Pharmaceutics, Vol 13, Iss 1643, p 1643 (2021)
Pharmaceutics
Volume 13
Issue 10
Pharmaceutics
Volume 13
Issue 10
Recent research indicates that selective NMDA receptor GluN2B subunit antagonists may become useful for the treatment of major depressive disorders. We aimed to examine in parallel the effect of the selective NMDA receptor GluN2B subunit antagonist C
Autor:
Przemysław J Danek, Jacek Wójcikowski, Agnieszka Basińska-Ziobroń, Renata Pukło, Władysława A. Daniel
Publikováno v:
Pharmacological Reports
Background Inhibition of cytochrome P450 (CYP) enzymes is the most common cause of harmful drug–drug interactions. The present study aimed at examining the inhibitory effect of the novel antipsychotic drug asenapine on the main CYP enzymes in human
Autor:
Pukło, Renata1 (AUTHOR) bartyzel@if-pan.krakow.pl, Bromek, Ewa1 (AUTHOR), Haduch, Anna1 (AUTHOR), Basińska-Ziobroń, Agnieszka1 (AUTHOR), Kuban, Wojciech1 (AUTHOR), Daniel, Władysława A.1 (AUTHOR) nfdaniel@cyf-kr.edu.pl
Publikováno v:
International Journal of Molecular Sciences. Dec2023, Vol. 24 Issue 23, p16840. 15p.